Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)

Sinil Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	74,628	73,149	87,711	96,840	128,314	247,300
Market Cap Growth	-14.42%	-16.60%	-9.43%	-24.53%	-48.11%	229.18%
Enterprise Value	39,464	41,173	69,844	73,664	110,106	234,589
Last Close Price	6560.00	6430.00	7485.32	8067.47	10558.89	20160.16
PE Ratio	5.99	5.12	6.43	7.97	19.21	32.78
PS Ratio	0.87	0.82	0.98	1.21	2.08	4.03
PB Ratio	0.51	0.50	0.65	0.79	1.13	2.30
P/TBV Ratio	0.52	0.51	0.66	0.80	1.15	2.33
P/FCF Ratio	6.93	5.93	56.56	29.03	16.41	109.40
P/OCF Ratio	3.91	3.22	5.79	7.08	11.50	22.36
EV/Sales Ratio	0.46	0.46	0.78	0.92	1.78	3.82
EV/EBITDA Ratio	2.06	1.98	3.61	4.07	8.80	21.22
EV/EBIT Ratio	2.93	2.71	4.99	5.39	13.80	35.43
EV/FCF Ratio	3.67	3.34	45.04	22.08	14.08	103.77
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.02	0.02	0.03	0.01	0.02	0.04
Debt / FCF Ratio	0.04	0.04	0.35	0.04	0.04	0.17
Asset Turnover	0.53	0.56	0.60	0.59	0.49	0.51
Inventory Turnover	2.05	2.15	2.42	2.40	2.22	2.33
Quick Ratio	3.28	3.32	3.27	2.95	3.46	3.44
Current Ratio	4.70	4.71	4.86	4.22	4.86	5.08
Return on Equity (ROE)	8.95%	10.16%	10.57%	10.28%	6.05%	7.23%
Return on Assets (ROA)	5.20%	5.98%	5.92%	6.28%	3.93%	3.41%
Return on Capital (ROIC)	5.94%	6.74%	6.76%	7.21%	4.51%	3.95%
Return on Capital Employed (ROCE)	9.00%	10.20%	10.10%	10.80%	6.80%	5.80%
Earnings Yield	16.96%	19.55%	15.55%	12.55%	5.21%	3.05%
FCF Yield	14.43%	16.85%	1.77%	3.45%	6.09%	0.91%
Payout Ratio	15.53%	13.74%	8.15%	8.89%	15.73%	14.92%
Buyback Yield / Dilution	0.02%	0.02%	-3.94%	1.05%	0.11%	2.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.